[HTML][HTML] Micro-dystrophin AAV vectors made by transient transfection and herpesvirus system are equally potent in treating mdx mouse muscle disease
CH Hakim, N Clément, LP Wasala, HT Yang… - … Therapy Methods & …, 2020 - cell.com
Vector production scale-up is a major barrier in systemic adeno-associated virus (AAV) gene
therapy. Many scalable manufacturing methods have been developed. However, the …
therapy. Many scalable manufacturing methods have been developed. However, the …
[HTML][HTML] Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease
CH Hakim, N Clément, LP Wasala, HT Yang… - … Therapy-Methods & …, 2020 - Elsevier
Vector production scale-up is a major barrier in systemic adeno-associated virus (AAV) gene
therapy. Many scalable manufacturing methods have been developed. However, the …
therapy. Many scalable manufacturing methods have been developed. However, the …
[引用][C] Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease
CH Hakim, N Clément, LP Wasala, HT Yang… - … Therapy-Methods & …, 2020 - cir.nii.ac.jp
Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are
Equally Potent in Treating mdx Mouse Muscle Disease | CiNii Research CiNii 国立情報学 …
Equally Potent in Treating mdx Mouse Muscle Disease | CiNii Research CiNii 国立情報学 …
Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease.
CH Hakim, N Clément, LP Wasala… - … therapy. Methods & …, 2020 - europepmc.org
Vector production scale-up is a major barrier in systemic adeno-associated virus (AAV) gene
therapy. Many scalable manufacturing methods have been developed. However, the …
therapy. Many scalable manufacturing methods have been developed. However, the …
[HTML][HTML] Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease
CH Hakim, N Clément, LP Wasala… - … Therapy. Methods & …, 2020 - ncbi.nlm.nih.gov
Vector production scale-up is a major barrier in systemic adeno-associated virus (AAV) gene
therapy. Many scalable manufacturing methods have been developed. However, the …
therapy. Many scalable manufacturing methods have been developed. However, the …
Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease
CH Hakim, N Clément, LP Wasala… - … therapy. Methods & …, 2020 - pubmed.ncbi.nlm.nih.gov
Vector production scale-up is a major barrier in systemic adeno-associated virus (AAV) gene
therapy. Many scalable manufacturing methods have been developed. However, the …
therapy. Many scalable manufacturing methods have been developed. However, the …